BeanScreen for July 2016

  • Posted by
  • on June 30th, 2016

“Far more money has been lost by investors preparing for corrections than has been lost in corrections themselves.”Peter Lynch

In the table below are our crème de la crème for July, along with the number of consecutive months each company has been on the list. We decided to pare down the list this month from 30 to 20 as part of our de-cluttering process. Tracking a stronger, more concentrated group of companies keeps us more focused.

As always, do your own due diligence cuz we ain’t pros! The BeanScreen is just an idea creator.

And check us out on the SparkFin app!

 

  Stock Months on List
Latest News, Notes, Links
EV/Revenue
EV/EBITDA
1. NTES 17 China’s NetEase Gets Its Game On With Aggressive Push In Mobile 4.4 13
2. TSM 24  June revenues +36% YoY, +11% MoM 4.6 7.1
3. LCI 15 “Paroxetine Extended Release Tablets is first major approval from our KU subsidiary” 3.3 6.9
4. UTHR 8  Q2 saw revenue +19% YoY 2.3 3.1
5. GILD 29  Announces Q2 earnings 3.6 5.2
6. AMBA 19 Drone market could reach $127B by 2020 4.3 19
7. NHTC 4  Saw Q2 revs +15%, adj net income +19% YoY 0.7 3.9
8. MNST 30  in the process of launching Monster in China later this year 10 27
9. PCLN 51  saw 54% increase in U.S. searches exploring fares to UK after Brexit 6.5 17
10. SWKS 11 we’re well positioned to cont capitalizing on powerful connectivity and Internet of Things” 2.9 7.2
11. PDLI 5 Q1 revenues declined 31%, adj net income +7% YoY 0.9 1.0
12. ANIK 31  Achieved revenue growth of 16% YoY in latest Q2. 6.1 10
13. EQM 10  Last 4 Q’s income data. 10 13
14. SLP 12 Posted a record Q2 along with a hefty 5yr contract award with research foundation 5.7 13
15. QIWI 8 Q1 results; Visa QIWI Wallet receives M-Wallet of the Year award 0.4  1.5
16. TARO 3  accepted the resignation of its Chief Financial Officer, Michael Kalb 4.9 7.4
17. ATHM 9  Going private? 3.1 9.6
18. ARMH 15  Gets bought out for $31.4B in cash by Japan’s SoftBank 12 27
19. ATW 3  Osprey rig added a contract term for just under 2 years starting Jan ’18. 1.7 2.8
20. BIIB 24  Loses Big MS Gamble As Anti-LINGO Fails Clinical Trial 4.8 8.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In this month: N/A

Out: N/A

 

2016 Buy List

Consecutive Months Tracker

 

The BeanScreen is based on fundamentals. Every month hundreds of companies are screened to create a “fundy health” index. Over time, an average score and rank is compiled for a select group of stocks. Below are the six categories (with weighting) that contribute to the screen:

  • 25% Growth Rates – YoY/TTM/3yr/5yr Sales, EPS, etc
  • 25% Profit Margins – TTM/5yr Gross, operating, net
  • 15% Financial Condition – D/E, BV/Sh, EV/Rev, FCF/Rev, etc
  • 15% Price Ratios – P/E, P/S, P/B, P/CF, PEG, FP/E
  • 15% Investment Returns – MRQ/5yr ROE, ROA, ROC
  • 5%  Misc. – 100D RSI, Short Ratio/Float, Ins Ownership, etc

Within each category are an assortment of parameters that are uploaded into the BeanScreen via Randy Hamerlink’s stock market functions add-in program for Excel. The data is bench-marked and scored using our custom formula.

Like us on Facebook!

 

disclosure: as of 7/15/16 we’re long the above mentioned – GILD, LCI, AMBA, SLP, QIWI, UTHR, ATW

Other stocks/ETFs we own: RMGN, PLUG, HHC, ELY, FNMAS, KMI, WMB, ALGT

 


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

blog comments powered by Disqus
Wall Street Bean Blog